U-CYTK

Q:CYTK - CYTOKINETICS INC - http://www.cytokinetics.com

02:33:58 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
CYTK - Q	2.0	65.00	·	66.25	0.2	64.80	-2.02	-3.0	1,112.3	71,361	10,460	64.81 65.42 63.90	110.25 25.98	18:33:20	Apr 24	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 10460

More trades...

Time ET	Ex	Price	Change	Volume
18:33:20	Q	66.00	-0.82	1
17:55:42	Q	65.4001	-1.4199	100
17:31:55	Q	64.80	-2.02	70,000
17:31:55	Q	64.80	-2.02	66,800
16:54:06	Q	65.60	-1.22	50
16:53:21	Q	65.48	-1.34	60
16:43:47	Q	65.43	-1.39	50
16:41:34	Q	65.00	-1.82	100
16:41:17	Q	64.99	-1.83	34
16:41:17	Q	65.00	-1.82	66

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2024-04-24 16:00	U:CYTK	News Release200	Cytokinetics to Announce First Quarter Results on May 8, 2024
2024-04-10 07:30	U:CYTK	News Release200	Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
2024-04-05 07:30	U:CYTK	News Release200	Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
2024-04-02 16:00	U:CYTK	News Release200	Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-04-01 16:00	U:CYTK	News Release200	Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Date ET

Symbol

Type

Headline

2024-04-24 16:00

U:CYTK

News Release

Cytokinetics to Announce First Quarter Results on May 8, 2024

2024-04-10 07:30

U:CYTK

News Release

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress